(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are BERGENBIO, SEQUANA MEDICAL, and BEAULIEU-AV. CERT.

The three biggest losers today are VIVORYON, AUBAY, and SLIGRO FOOD GROUP.

Winners today

1. BERGENBIO (BGBIO.OL)

25% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO rising 25% to €0.23 on Thursday, after three sequential sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 1.6% to €1,291.25, following the last session’s upward trend on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.83.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Moving Average

BERGENBIO’s worth is way higher than its 50-day moving average of kr0.13 and way under its 200-day moving average of kr4.18.

More news about BERGENBIO.

2. SEQUANA MEDICAL (SEQUA.BR)

13.36% Price Change

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.

BEL 20 ended the session with SEQUANA MEDICAL jumping 13.36% to €2.80 on Thursday while BEL 20 slid 1.86% to €3,398.58.

Earnings Per Share

As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.36.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -690.43%.

Volume

Today’s last reported volume for SEQUANA MEDICAL is 19238 which is 136.54% above its average volume of 8133.

Volatility

SEQUANA MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.83%, a negative 1.45%, and a positive 2.76%.

SEQUANA MEDICAL’s highest amplitude of average volatility was 5.10% (last week), 2.81% (last month), and 2.76% (last quarter).

More news about SEQUANA MEDICAL.

3. BEAULIEU-AV. CERT (BEAB.BR)

9.84% Price Change

Immo-Beaulieu NV owns and operates real estate properties. The company is based in Brussels, Belgium. Immo-Beaulieu NV operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BEAULIEU-AV. CERT jumping 9.84% to €4.02 on Thursday, after five consecutive sessions in a row of losses. BEL 20 fell 1.86% to €3,398.58, after two successive sessions in a row of losses, on what was an all-around negative trend trading session today.

More news about BEAULIEU-AV. CERT.

4. MOLTEN VENTURES (GRW.IR)

9.68% Price Change

Molten Ventures Plc, formerly known as Draper Esprit plc, is a private equity and venture capital firm specializing in any stage in the lifecycle of a business from seed and series A stage, growth capital to pre-IPO investments, late stage, start-ups, cross-stage investments, buyouts, PIPES, and also makes direct and secondary investments in portfolio companies. It also seeks to buy entire funds from other tech investors. The firm primarily invests in companies from pre-revenue stage upwards. It primarily invests in technology oriented business. The firm typically invests in digital technology, consumer, commerce, enterprise and data, systems and semiconductors, financial technology, internet, mobile, media, telecom, consumer technology, enterprise technology, SaaS, fintech, deeptech, digital health & wellness and healthcare sectors, prop tech, software, hardware, medical technology, and life sciences sectors. It invests in companies based in Europe, United states, Austria, Belgium, Denmark, Germany, Finland, France, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Ireland, and United Kingdom. The firm seeks to invest between $0.02 million and €10 million ($10.88 million) in rounds up to €1 million ($1.09 million) and €30 million ($32.63 million). It invests 30 percent of its corpus in very early stage companies with less than $5 million in revenues. The firm seeks to make minority and majority investments. Molten Ventures Plc was founded in 1984 and is based in London, United Kingdom with an additional offices in Dublin, Ireland.

ISEQ All Share ended the session with MOLTEN VENTURES rising 9.68% to €2.72 on Thursday, after five consecutive sessions in a row of losses. ISEQ All Share slid 1.61% to €7,982.81, after two sequential sessions in a row of losses, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, MOLTEN VENTURES has a trailing twelve months EPS of €-1.84.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.52%.

More news about MOLTEN VENTURES.

5. VEON (VEON.AS)

9.19% Price Change

VEON Ltd., together with its subsidiaries, provides mobile and fixed-line telecommunications services It offers voice, data, and other telecommunication services through a range of wireless, fixed, and broadband internet services. The company provides value-added services, including short messages, multimedia messages, caller number identification, call waiting, data transmission, mobile internet, downloadable content, mobile finance, machine-to-machine, and other services; national and international roaming services; wireless internet access; internet-TV services; digital and systems integration services; mobile financial services; and mobile bundles and call completion services. It offers value-added services for corporations, operators, and consumers, as well as sells equipment, infrastructure, and accessories. The company provides its services under the Beeline, Kyicvcstar, Jazz, Djezzy, and banglalink brands in Russia, Pakistan, Algeria, Uzbekistan, Ukraine, Bangladesh, Kazakhstan, Kyrgyzstan, and Georgia. The company was formerly known as VimpelCom Ltd. and changed its name to VEON Ltd. in March 2017. VEON Ltd. was founded in 1992 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with VEON jumping 9.19% to €0.62 on Thursday, after five successive sessions in a row of losses. AEX-Index fell 0.27% to €727.61, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, VEON has a trailing twelve months EPS of €0.26.

PE Ratio

VEON has a trailing twelve months price to earnings ratio of 2.38. Meaning, the purchaser of the share is investing €2.38 for every euro of annual earnings.

More news about VEON.

6. SAS AB (SASNO.OL)

7.36% Price Change

SAS AB (publ), together with its subsidiaries, provides passenger flight transportation services in the Nordic and international route network. The company also offers air cargo services, in-flight sales, ground handling, and technical maintenance services, as well as travel-related loyalty programs. It operates a fleet of 135 aircraft, including 12 long-haul aircraft, 95 short-haul aircraft, and 28 aircraft flown by regional production partners. The company was founded in 1946 and is headquartered in Stockholm, Sweden. On July 5, 2022, SAS AB (publ), along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

Oslo Børs Benchmark Index_GI ended the session with SAS AB jumping 7.36% to €0.06 on Thursday while Oslo Børs Benchmark Index_GI fell 1.6% to €1,291.25.

Earnings Per Share

As for profitability, SAS AB has a trailing twelve months EPS of kr-0.57.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SAS AB’s EBITDA is 0.85.

More news about SAS AB.

7. BELYSSE GROUP (BELYS.BR)

5.49% Price Change

Belysse Group NV produces and sells textile floor coverings for commercial and residential applications in Europe, North America, and internationally. The company designs, manufactures, and distributes broadloom carpets and modular carpet tiles primarily for offices and public projects. It commercializes its products under the Bentley, modulyss, arc edition, and ITC brands. The company was formerly known as Balta Group NV and changed its name to Belysse Group NV in October 2022. Belysse Group NV was founded in 1964 and is headquartered in Waregem, Belgium. Belysse Group NV is a subsidiary of LSF9 Belysse Holdco S.à r.l.

BEL 20 ended the session with BELYSSE GROUP jumping 5.49% to €0.73 on Thursday, following the last session’s downward trend. BEL 20 fell 1.86% to €3,398.58, after two successive sessions in a row of losses, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, BELYSSE GROUP has a trailing twelve months EPS of €-0.42.

More news about BELYSSE GROUP.

8. BORGESTAD (BOR.OL)

5.38% Price Change

Borgestad ASA develops, manufactures, distributes, and installs refractory products in Norway. The company also develops and manages real estate properties. Its properties include Agora Bytom, a shopping center with a gross area of 52,000 square meters and a rental area of approximately 30,000 square meters, as well as a parking garage with 820 parking lots in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD jumping 5.38% to €1.37 on Thursday, after four consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 1.6% to €1,291.25, following the last session’s upward trend on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.82.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 400% and 100%, respectively.

Sales Growth

BORGESTAD’s sales growth is 6.6% for the present quarter and 4% for the next.

Volume

Today’s last reported volume for BORGESTAD is 11072 which is 74.73% below its average volume of 43831.

Yearly Top and Bottom Value

BORGESTAD’s stock is valued at kr1.37 at 22:40 EST, way below its 52-week high of kr2.02 and way above its 52-week low of kr1.23.

More news about BORGESTAD.

9. SMARTCRAFT (SMCRT.OL)

5.31% Price Change

SmartCraft ASA provides software solutions to the construction industry in Norway, Sweden, and Finland. The company offers Cordel; Bygglet, a SaaS born in the cloud solution; EL-VIS, a solution for electricians; and Congrid, a cloud-based tool for project management in construction companies. It also provides HomeRun, a digital tool for construction, project communication, document, and procurement management; Kvalitetskontroll, a cloud-based project management solution and quality assurance platform for construction companies; El-verdi, a digital sales tool for electricians; and ELinn, a cloud based solution for electricians to handle project management services. The company was founded in 1987 and is headquartered in Hønefoss, Norway.

Oslo Børs Benchmark Index_GI ended the session with SMARTCRAFT rising 5.31% to €21.80 on Thursday while Oslo Børs Benchmark Index_GI dropped 1.6% to €1,291.25.

Earnings Per Share

As for profitability, SMARTCRAFT has a trailing twelve months EPS of kr0.52.

PE Ratio

SMARTCRAFT has a trailing twelve months price to earnings ratio of 41.92. Meaning, the purchaser of the share is investing kr41.92 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.51%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SMARTCRAFT’s EBITDA is 72.73.

More news about SMARTCRAFT.

10. UNIFIEDPOST GROUP (UPG.BR)

5.05% Price Change

UnifiedPost Group SA, a fintech company, operates and develops a cloud-based platform for administrative and financial services in Belgium and internationally. Its platform allows connections between its customers, suppliers, customers, and other parties in the financial supply chain. The company offers a technology portfolio for document processing, identity management, payment services, and added value financial services, as well as engages in post and parcel optimization activities. It serves corporate and government customers; small and medium-sized enterprises; and agricultural, accounting, interim, and construction sectors. UnifiedPost Group SA was founded in 2001 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with UNIFIEDPOST GROUP jumping 5.05% to €2.60 on Thursday while BEL 20 dropped 1.86% to €3,398.58.

Earnings Per Share

As for profitability, UNIFIEDPOST GROUP has a trailing twelve months EPS of €-1.33.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -29.78%.

Yearly Top and Bottom Value

UNIFIEDPOST GROUP’s stock is valued at €2.60 at 22:40 EST, way below its 52-week high of €5.08 and way above its 52-week low of €2.07.

More news about UNIFIEDPOST GROUP.

Losers Today

1. VIVORYON (VVY.AS)

-24.57% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON sliding 24.57% to €7.92 on Thursday, following the last session’s downward trend. AEX-Index dropped 0.27% to €727.61, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, VIVORYON’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for VIVORYON is 479691 which is 1122.6% above its average volume of 39235.

More news about VIVORYON.

2. AUBAY (AUB.PA)

-12.43% Price Change

Aubay Société Anonyme provides application services in Belgium, Luxembourg, Spain, Portugal, Italy, France, and the United Kingdom. The company offers consulting; digital experience services, such as service design thinking/design strategist, UX design/UX digital designer, UI design/UI digital designer, and product management/product owner digital; smart automation/intelligent process automation services, including audit and business process optimization, process mining, OCR and intelligent document processing, NLP and NLU, and machine learning/deep learning; and agility services, such as maturity audit, training and support, and operational agility. It also provides application services; data and analytics services comprising data governance, data platform, data science, and Dataviz and business intelligence; cybersecurity services, such as governance, risk, compliance consulting, project and development security, and secure architecture; cloud infrastructure; and test and automation services. It serves banking/finance, public, health, energy, distribution, insurance, industry, network/telecoms, and services/utilities sectors. Aubay Société Anonyme was incorporated in 1944 and is based in Boulogne-Billancourt, France.

CAC 40 ended the session with AUBAY falling 12.43% to €29.95 on Thursday while CAC 40 fell 0.64% to €6,921.37.

Earnings Per Share

As for profitability, AUBAY has a trailing twelve months EPS of €2.64.

PE Ratio

AUBAY has a trailing twelve months price to earnings ratio of 11.34. Meaning, the purchaser of the share is investing €11.34 for every euro of annual earnings.

Volume

Today’s last reported volume for AUBAY is 65699 which is 843% above its average volume of 6967.

More news about AUBAY.

3. SLIGRO FOOD GROUP (SLIGR.AS)

-8.62% Price Change

Sligro Food Group N.V. engages in the foodservice businesses in the Netherlands and Belgium. The company offers a range of food and food-related non-food products; and services in the food and beverages wholesale market. It operates a network of cash-and-carry and delivery service sites to serve hospitality industry, leisure facilities, caterers, large-volume users, company restaurants, petrol stations, small and medium-sized enterprises, small retail businesses, and the institutional markets under the Sligro, De Kweker, and Van Hoeckel brand names in the Netherlands. It also serves institutional, corporate catering, and hotel chain segments under the JAVA Foodservice name; and hospitality industry, culinary professionals, and wholesale delivery service outlets under the Silgro-ISPC name through a network of two cash-and-carry and delivery service sites. In addition, the company is involved in the production of convenience and fresh fish products; sourcing of meat, game and poultry, fruits and vegetables, and bread and pastries; advertise, design, delivery, install, and maintenance of professional kitchen, kitchen equipment, and refrigeration and freezing equipment; and provision of online gift concepts and Christmas gifts, and traditional Christmas hampers. It also offers its products through online platform. Sligro Food Group N.V. was founded in 1935 and is headquartered in Veghel, the Netherlands.

AEX-Index ended the session with SLIGRO FOOD GROUP dropping 8.62% to €15.90 on Thursday, after three sequential sessions in a row of gains. AEX-Index dropped 0.27% to €727.61, following the last session’s downward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, SLIGRO FOOD GROUP has a trailing twelve months EPS of €0.35.

PE Ratio

SLIGRO FOOD GROUP has a trailing twelve months price to earnings ratio of 45.43. Meaning, the purchaser of the share is investing €45.43 for every euro of annual earnings.

Volume

Today’s last reported volume for SLIGRO FOOD GROUP is 63867 which is 163.15% above its average volume of 24270.

More news about SLIGRO FOOD GROUP.

4. BYGGMA (BMA.OL)

-7.84% Price Change

Byggma ASA manufactures and supplies building materials in Norway, Sweden, Denmark, Finland, the United Kingdom, the Netherlands, and internationally. It offers pre-painted ceilings and wall panels under the Huntonit brand name; I-beams for use in ceilings, walls, and floors in wood-based buildings under the brand name of Masonite; and particle boards, boards, and structural panels for use in buildings, interior ceilings, and wall panels under the Forestia brand name. The company also provides home lighting products under the Scan Lamps brand name; doors and windows for new buildings, extensions, and rehabilitation under the brand name of Uldal; a range of lamp and lighting products under the Aneta brand name; and develops, manufactures, and distributes MDF panels for walls, ceilings, bathrooms, and kitchens under the brand name of Smartpanel, as well as supplies OSB plywood and building boards under the brand name of Byggform. It exports its products. Byggma ASA is headquartered in Vennesla, Norway. Byggma ASA operates as a subsidiary of Investor As.

Oslo Børs Benchmark Index_GI ended the session with BYGGMA sliding 7.84% to €17.05 on Thursday while Oslo Børs Benchmark Index_GI dropped 1.6% to €1,291.25.

Earnings Per Share

As for profitability, BYGGMA has a trailing twelve months EPS of kr2.67.

PE Ratio

BYGGMA has a trailing twelve months price to earnings ratio of 6.39. Meaning, the purchaser of the share is investing kr6.39 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.78%.

Yearly Top and Bottom Value

BYGGMA’s stock is valued at kr17.05 at 22:40 EST, way below its 52-week low of kr22.30.

More news about BYGGMA.

5. NAPATECH (NAPA.OL)

-7.83% Price Change

Napatech A/S offers reconfigurable computing solutions for the networking and cybersecurity applications worldwide. The company provides Link Capture Software that enables packet capture with nanosecond timestamping and replay with precise inter-frame gap control; Link Inline Software, which offers a processing architecture that offloads and accelerates flow aware application data planes; Link Virtualization Software that offloads and accelerates the Open vSwitch data plane to enhance CPU efficiency and network performance; and Link Programmable, which enables end users and OEMs to deploy FPGA computation solutions. It also offers solutions for telecom operators, cloud and data center service providers, and infrastructure and defense, as well as financial services, cyber security, network management, and virtualization. The company was incorporated in 2003 and is headquartered in Copenhagen, Denmark.

Oslo Børs Benchmark Index_GI ended the session with NAPATECH sliding 7.83% to €10.60 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI fell 1.6% to €1,291.25, following the last session’s upward trend on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, NAPATECH has a trailing twelve months EPS of kr-1.1.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.61%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NAPATECH’s stock is considered to be overbought (>=80).

More news about NAPATECH.

6. ATLANTIC SAPPHIRE (ASA.OL)

-7.69% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE dropping 7.69% to €1.49 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 1.6% to €1,291.25, following the last session’s upward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-7.09.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Moving Average

ATLANTIC SAPPHIRE’s worth is way under its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

More news about ATLANTIC SAPPHIRE.

7. HYDROGENPRO (HYPRO.OL)

-7.63% Price Change

HydrogenPro ASA designs and supplies customized hydrogen plants. It provides high-pressure alkaline electrolysers. The company was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO sliding 7.63% to €14.78 on Thursday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI slid 1.6% to €1,291.25, following the last session’s upward trend on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-0.75.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.4%.

Volatility

HYDROGENPRO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.72%, a negative 0.73%, and a positive 2.63%.

HYDROGENPRO’s highest amplitude of average volatility was 3.78% (last week), 2.96% (last month), and 2.63% (last quarter).

Volume

Today’s last reported volume for HYDROGENPRO is 279627 which is 244.16% above its average volume of 81249.

Moving Average

HYDROGENPRO’s worth is way below its 50-day moving average of kr18.97 and way below its 200-day moving average of kr24.69.

Sales Growth

HYDROGENPRO’s sales growth is 610.8% for the ongoing quarter and 203.5% for the next.

More news about HYDROGENPRO.

8. UCB (UCB.BR)

-7.46% Price Change

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with UCB dropping 7.46% to €72.42 on Thursday, after four successive sessions in a row of losses. BEL 20 dropped 1.86% to €3,398.58, after two sequential sessions in a row of losses, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, UCB has a trailing twelve months EPS of €1.7.

PE Ratio

UCB has a trailing twelve months price to earnings ratio of 42.6. Meaning, the purchaser of the share is investing €42.6 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.7%.

More news about UCB.

9. AB SCIENCE (AB.PA)

-7.2% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE falling 7.2% to €2.45 on Thursday while CAC 40 slid 0.64% to €6,921.37.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.36.

Yearly Top and Bottom Value

AB SCIENCE’s stock is valued at €2.45 at 22:40 EST, way below its 52-week low of €2.73.

Moving Average

AB SCIENCE’s value is way under its 50-day moving average of €3.77 and way below its 200-day moving average of €5.72.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AB SCIENCE’s stock is considered to be oversold (<=20).

More news about AB SCIENCE.

10. EQVA (EQVA.OL)

-6.69% Price Change

Eqva ASA, a knowledge-based maritime company, primarily engages in the shipbuilding business worldwide. It operates in two segments, Shipbuilding Technology and Other. The company provides newbuilding, rebuilding, and service assignments on vessels for offshore oil production, renewable energy production, fishing, and fish farming for ship owners. It delivers technology for customers within the seafood, energy, and transport sectors. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was founded in 1999 and is headquartered in Fosnavåg, Norway.

Oslo Børs Benchmark Index_GI ended the session with EQVA sliding 6.69% to €2.51 on Thursday while Oslo Børs Benchmark Index_GI slid 1.6% to €1,291.25.

Earnings Per Share

As for profitability, EQVA has a trailing twelve months EPS of kr-0.32.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.

More news about EQVA.

Stay up to date with our winners and losers daily report